The invention relates to crystalline forms (II and III) of Tulathromycin of formula (I) and to methods for the preparation of the same. The present inventon, in addition, relates to the use of crystalline forms (II and III) of Tulathromycin as an anti-infective medicament for treating bacterial infections in animals.